Recent evidence has shown that oxidative stress associated with many cardiopulmonary diseases shifts intracellular native sGC levels towards the apo-sGC form [47, 48], providing the rationale for sGC activators [49–52] in cardiopulmonary diseases and PH. This evidence concerns the gene SGCB and cor pulmonale.